KX2-391 ointment

KX2-391 · Athenex, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KX2-391 ointment, covering 2018-07-06 to 2021-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp [Phase 2]